We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWindsor Framework replaces the Northern Ireland protocol to address issues and provide significant c...
Read moreMHRA announces UK will introduce new framework aimed at making the manufacture of innovative medicin...
Read moreWe summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe MHRA awards Innovation Passports to those products it deems innovative, in order for them to be ...
Read moreIntroduction Following Brexit, regulatory oversight in the UK has switched from the European Medicin...
Read morePatients in England will be the first in Europe to have access to Takeda’s Exkivity (mobocertinib)...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreFollowing Brexit, the Medicines and Healthcare Regularoty Agency (MHRA) has become the UK's sole bod...
Read more